Organic compounds -- part of the class 532-570 series – Organic compounds – Nitrogen attached directly or indirectly to the purine ring...
Reexamination Certificate
2009-08-13
2010-06-08
Bernhardt, Emily (Department: 1624)
Organic compounds -- part of the class 532-570 series
Organic compounds
Nitrogen attached directly or indirectly to the purine ring...
C544S363000
Reexamination Certificate
active
07732600
ABSTRACT:
Disclosed are methods for the preparation of compounds of formula (I):wherein R1, m, X, R2, n, W, p, Y, Z, R3, R4, R5and q have the meanings as defined in the description.
REFERENCES:
patent: 3937708 (1976-02-01), Mentrup et al.
patent: 3975525 (1976-08-01), Mentrup et al.
patent: 3992537 (1976-11-01), Mentrup et al.
patent: 4891375 (1990-01-01), Lowe, III
patent: 4933447 (1990-06-01), Koono et al.
patent: 5430033 (1995-07-01), Cliffe et al.
patent: 5627177 (1997-05-01), Cliffe et al.
patent: 5965560 (1999-10-01), Glase et al.
patent: 6121267 (2000-09-01), Glase et al.
patent: 6214829 (2001-04-01), Feenstra et al.
patent: 6759435 (2004-07-01), Chen
patent: 6825189 (2004-11-01), Peters et al.
patent: 6897219 (2005-05-01), Peters et al.
patent: 7279481 (2007-10-01), Falchi et al.
patent: 7459456 (2008-12-01), Biagetti, et al.
patent: 2002/0094986 (2002-07-01), Chappell et al.
patent: 2004/0048869 (2004-03-01), Chappell et al.
patent: 2004/0072823 (2004-04-01), Peters et al.
patent: 2005/0124625 (2005-06-01), Salvati et al.
patent: 2005/0282236 (2005-12-01), Gaeta et al.
patent: 2005/0287617 (2005-12-01), Gaeta et al.
patent: 2006/0264429 (2006-11-01), Bertani et al.
patent: 308897 (1989-03-01), None
patent: 673927 (1995-09-01), None
patent: 742207 (1996-11-01), None
patent: 0900792 (1999-03-01), None
patent: 1213031 (2002-06-01), None
patent: 2277517 (1994-11-01), None
patent: 2312843 (1997-11-01), None
patent: 58083677 (1983-05-01), None
patent: 63054363 (1988-10-01), None
patent: 02169569 (1990-06-01), None
patent: 2777159 (1998-07-01), None
patent: WO9415919 (1994-07-01), None
patent: WO9415928 (1994-07-01), None
patent: WO 97/36893 (1997-10-01), None
patent: WO9741108 (1997-11-01), None
patent: WO9825617 (1998-06-01), None
patent: WO9921834 (1999-05-01), None
patent: WO 99/31086 (1999-06-01), None
patent: WO0078716 (2000-12-01), None
patent: WO 01/32626 (2001-05-01), None
patent: 02/074764 (2002-09-01), None
patent: WO200294203 (2002-11-01), None
patent: WO2004035556 (2004-04-01), None
patent: WO2004041793 (2004-05-01), None
patent: WO2004046124 (2004-06-01), None
patent: WO2004074218 (2004-09-01), None
patent: WO2005014552 (2005-02-01), None
patent: WO2005 040136 (2005-05-01), None
patent: WO2005087742 (2005-09-01), None
patent: WO2006024517 (2006-03-01), None
Robichaud et al.Annual Reports in Medicinal Chemistry, 35: 11-20 (2000).
Jones et al.Pharmacology, Biochemistry, and Behavior, 71: 555-568 (2002).
Bergauer Markus
Bertani Barbara
Biagetti Matteo
Bromidge Steven Mark
Falchi Alessandro
Bernhardt Emily
Fitch Duke M.
Glaxo Group Limited
Ling Lorraine B.
Sieburth Kathryn L.
LandOfFree
Quinoline and quinazoline derivatives having affinity for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Quinoline and quinazoline derivatives having affinity for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinoline and quinazoline derivatives having affinity for... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4237275